Titan Pharmaceuticals
TTNP
#10532
Rank
A$8.6 M
Marketcap
A$6.47
Share price
-3.76%
Change (1 day)
4.09%
Change (1 year)

Earnings for Titan Pharmaceuticals (TTNP)

Earnings in 2025 (TTM): -A$4.33 Million

According to Titan Pharmaceuticals 's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -A$6.61 Million, an increase over its 2023 earnings that were of -A$7.82 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Titan Pharmaceuticals from 1995 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$4.33 Million-34.55%
2024 -A$6.61 Million-15.5%
2023 -A$7.82 Million-45.43%
2022 -A$14.33 Million16.29%
2021 -A$12.32 Million-907.36%
2020 A$1.52 M-106.6%
2019 -A$23.1 Million82.4%
2018 -A$12.67 Million-36.93%
2017 -A$20.08 Million-378.62%
2016 A$7.2 M-145.53%
2015 -A$15.84 Million369.37%
2014 -A$3.38 Million-125.9%
2013 A$13.02 M-177.74%
2012 -A$16.75 Million13.59%
2011 -A$14.75 Million74.37%
2010 -A$8.46 Million3.61%
2009 -A$8.17 Million
2007 -A$25.88 Million12.08%
2006 -A$23.09 Million-28.65%
2005 -A$32.36 Million-10.03%
2004 -A$35.96 Million-6.08%
2003 -A$38.29 Million-14.76%
2002 -A$44.92 Million32.52%
2001 -A$33.9 Million27.55%
2000 -A$26.58 Million62.5%
1999 -A$16.36 Million4.04%
1998 -A$15.72 Million49.33%
1997 -A$10.53 Million-27.88%
1996 -A$14.6 Million13.04%
1995 -A$12.92 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$47.09 B-1,196,249.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$22.95 B-583,059.00%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Vanda Pharmaceuticals
VNDA
-A$0.17 Billion 4,217.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
A$0.11 B-3,090.94%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-A$16.85 Million 327.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-A$0.41 Billion 10,144.78%๐Ÿ‡บ๐Ÿ‡ธ USA